Ute Reuning

5.2k total citations · 1 hit paper
83 papers, 4.3k citations indexed

About

Ute Reuning is a scholar working on Cancer Research, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Ute Reuning has authored 83 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cancer Research, 39 papers in Immunology and Allergy and 30 papers in Molecular Biology. Recurrent topics in Ute Reuning's work include Cell Adhesion Molecules Research (39 papers), Protease and Inhibitor Mechanisms (37 papers) and Blood Coagulation and Thrombosis Mechanisms (22 papers). Ute Reuning is often cited by papers focused on Cell Adhesion Molecules Research (39 papers), Protease and Inhibitor Mechanisms (37 papers) and Blood Coagulation and Thrombosis Mechanisms (22 papers). Ute Reuning collaborates with scholars based in Germany, United States and Italy. Ute Reuning's co-authors include Horst Kessler, Manfred Schmitt, Viktor Magdolen, H. Graeff, Hans‐Jürgen Wester, Olaf G. Wilhelm, Markus Schwaiger, Johannes Notni, Nadia Harbeck and Heinz Höfler and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Ute Reuning

81 papers receiving 4.2k citations

Hit Papers

A Comprehensive Evaluation of the Activity and Selectivit... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ute Reuning Germany 34 1.8k 1.5k 1.3k 1.2k 639 83 4.3k
Achim Krüger Germany 45 2.6k 1.4× 2.2k 1.4× 631 0.5× 2.1k 1.8× 486 0.8× 111 5.8k
Rafael Fridman United States 31 2.5k 1.4× 2.4k 1.5× 1.0k 0.8× 1.8k 1.5× 757 1.2× 52 5.5k
Akira Komoriya United States 30 2.9k 1.6× 774 0.5× 1.7k 1.3× 867 0.7× 452 0.7× 55 5.6k
Staffan Strömblad Sweden 35 3.4k 1.8× 1.8k 1.1× 2.4k 1.8× 1.4k 1.2× 567 0.9× 72 6.1k
Walter E. Laug United States 33 1.6k 0.9× 1.3k 0.8× 803 0.6× 747 0.6× 511 0.8× 73 3.6k
Dwayne G. Stupack United States 46 4.4k 2.4× 1.2k 0.8× 2.3k 1.7× 1.5k 1.2× 370 0.6× 109 7.3k
Andries Zijlstra United States 38 2.7k 1.4× 1.3k 0.8× 645 0.5× 1.1k 1.0× 180 0.3× 84 4.6k
Jay S. Desgrosellier United States 19 2.7k 1.5× 770 0.5× 1.7k 1.3× 1.6k 1.4× 152 0.2× 30 4.9k
Birgit Leitinger United Kingdom 38 2.0k 1.1× 628 0.4× 2.7k 2.0× 1.1k 0.9× 342 0.5× 54 5.2k
Ulrich H. Weidle Germany 48 3.9k 2.1× 2.3k 1.5× 924 0.7× 2.0k 1.7× 784 1.2× 160 6.7k

Countries citing papers authored by Ute Reuning

Since Specialization
Citations

This map shows the geographic impact of Ute Reuning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Reuning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Reuning more than expected).

Fields of papers citing papers by Ute Reuning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Reuning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Reuning. The network helps show where Ute Reuning may publish in the future.

Co-authorship network of co-authors of Ute Reuning

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Reuning. A scholar is included among the top collaborators of Ute Reuning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Reuning. Ute Reuning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reuning, Ute, et al.. (2024). CRISPR/Cas9-mediated knock out of ITGB6 in human OSCC cells reduced migration and proliferation ability. Head & Face Medicine. 20(1). 37–37. 2 indexed citations
2.
Liu, Yueyang, Weiwei Gong, Julia Dorn, et al.. (2022). A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression. Life. 12(10). 1517–1517. 7 indexed citations
3.
Beaufort, Nathalie, Daniela Loessner, Matthias Kotzsch, et al.. (2021). Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells. Molecular Medicine. 27(1). 158–158. 5 indexed citations
4.
Kryza, Thomas, S. Lovell, Brittney S. Harrington, et al.. (2021). Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1. Nature Chemical Biology. 17(7). 776–783. 16 indexed citations
5.
Ludwig, Beatrice Stefanie, Horst Kessler, Susanne Kossatz, & Ute Reuning. (2021). RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field. Cancers. 13(7). 1711–1711. 145 indexed citations
6.
Kapp, Tobias G., Florian Rechenmacher, Stefanie Neubauer, et al.. (2017). A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins. Scientific Reports. 7(1). 39805–39805. 445 indexed citations breakdown →
7.
Kessler, Horst, et al.. (2014). Cytoplasmic salt bridge formation in integrin αvß3 stabilizes its inactive state affecting integrin-mediated cell biological effects. Cellular Signalling. 26(11). 2493–2503. 15 indexed citations
8.
Abou‐Ajram, Claudia, et al.. (2009). Integrin αvβ3 upregulates integrin‐linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription. Journal of Cellular Physiology. 220(2). 367–375. 30 indexed citations
9.
Hutzler, Peter, Matthias Kotzsch, Birgit Luber, et al.. (2009). Tumor suppressor KAI1 affects integrin αvβ3-mediated ovarian cancer cell adhesion, motility, and proliferation. Experimental Cell Research. 315(10). 1759–1771. 42 indexed citations
10.
Hiendlmeyer, Elke, Susanne Regus, Falk Hlubek, et al.. (2004). β-Catenin Up-Regulates the Expression of the Urokinase Plasminogen Activator in Human Colorectal Tumors. Cancer Research. 64(4). 1209–1214. 76 indexed citations
11.
Sinner, Eva‐Kathrin, Ute Reuning, Fatma Neşe Kök, et al.. (2004). Incorporation of integrins into artificial planar lipid membranes: characterization by plasmon-enhanced fluorescence spectroscopy. Analytical Biochemistry. 333(2). 216–224. 36 indexed citations
12.
Muehlenweg, Bernd, Andreas Schnelzer, Ernst Lengyel, et al.. (2003). RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator Gene. Humana Press eBooks. 39. 299–306. 1 indexed citations
13.
Reuning, Ute, S. Sperl, Charlotte Kopitz, et al.. (2003). Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo. Current Pharmaceutical Design. 9(19). 1529–1543. 52 indexed citations
14.
Reuning, Ute, et al.. (2003). Molecular and Functional Interdependence of the Urokinase-Type Plasminogen Activator System with Integrins. Biological Chemistry. 384(8). 1119–31. 50 indexed citations
15.
Magdolen, Viktor, S. Sperl, Bernd Muehlenweg, et al.. (2002). Natural and Synthetic Inhibitors of The Tumor-Associated Serine Protease Urokinase-Type Plasminogen Activator. Advances in experimental medicine and biology. 477. 331–341. 14 indexed citations
16.
Marschall, Christoph, et al.. (1999). UVB Increases Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression1. Journal of Investigative Dermatology. 113(1). 69–76. 28 indexed citations
17.
Kühn, W., Barbara Schmalfeldt, Ute Reuning, et al.. (1999). Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. British Journal of Cancer. 79(11-12). 1746–1751. 110 indexed citations
18.
Ma, Shwu‐Fan, Joe G. N. Garcia, Ute Reuning, et al.. (1997). Thrombin induces thrombomodulin mRNA expression via the proteolytically activated thrombin receptor in cultured bovine smooth muscle cells. Journal of Laboratory and Clinical Medicine. 129(6). 611–619. 11 indexed citations
19.
Koppitz, Marcus, Horst Kessler, Bernhard König, et al.. (1997). Inhibition of the Interaction of Urokinase-Type Plasminogen Activator (uPA) with Its Receptor (uPAR) by Synthetic Peptides. Biological Chemistry. 378(3-4). 231–7. 56 indexed citations
20.
Schmalfeldt, Barbara, W. Kühn, Ute Reuning, et al.. (1995). Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.. PubMed. 55(18). 3958–63. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026